Data from Hotspot <i>ESR1</i> Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis
Zheqi Li(Sun Yat-sen University), Steffi Oesterreich(University of Pittsburgh), Azadeh Nasrazadani(The University of Texas MD Anderson Cancer Center), Youbin Zhang(Northwestern University), Dorraya El‐Ashry(University of Miami), Elena Guerini‐Rocco(European Institute of Oncology), Megan E. Yates(University of Pittsburgh), Amir Bahreini(University of Pittsburgh), Kevin M. Levine(University of Pittsburgh), George C. Tseng(University of Pittsburgh), Jens‐Uwe Blohmer(Sankt Gertrauden Krankenhaus), Paul Jank(Universitätsklinikum Gießen und Marburg), Jennifer K. Richer(University of Colorado Anschutz Medical Campus), Callen T. Wallace(University of Pittsburgh), Massimo Cristofanilli(Cornell University), Carsten Denkert(Philipps University of Marburg), Nolan Priedigkeit(University of Pittsburgh), Jason Gertz(University of Utah), Spencer Arnesen(University of Utah), Adrian V. Lee(Baylor College of Medicine), Benjamin Troness(University of Minnesota Medical Center), Maritza A. Montanez(University of Pittsburgh), Lorenzo Gerratana(National Cancer Institute), Simak Ali(The London College), Nilgun Tasdemir(Memorial Sloan Kettering Cancer Center), Peter C. Lucas(University of Pittsburgh), Maria Margarete Karsten(Charité - Universitätsmedizin Berlin), Caterina Fumagalli(European Institute of Oncology), Nikhil Wagle(Dana-Farber Cancer Institute), Laki Buluwela(The London College), Jason S. Carroll(Cancer Research UK Cambridge Center), Simon C. Watkins(University of Pittsburgh), Prithu Sundd, Ben Ho Park(Vanderbilt University Medical Center), Jian Chen(University of Science and Technology of China), Qiang Zhang(Northwestern University), Yang‐Chang Wu(Kaohsiung Medical University), Jennifer M. Atkinson(University of Pittsburgh), Li Zhu(University of Pittsburgh)
Cited by 0
Related Papers
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
|Cell|2018|4k
The Consensus Coding Sequences of Human Breast and Colorectal Cancers
|Science|2006|3.2k
Pembrolizumab for Early Triple-Negative Breast Cancer
|New England Journal of Medicine|2020|3.1k
The Genomic Landscapes of Human Breast and Colorectal Cancers
|Science|2007|2.8k